ISRCTN17073439
Completed
未知
A pilot randomised controlled clinical trial of 3D-printed dentures
niversity of Leeds0 sites18 target enrollmentJuly 22, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Preference for type of dentures
- Sponsor
- niversity of Leeds
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who:
- •1\. Have no natural teeth
- •2\. Are available for follow up
- •3\. Require replacement complete dentures
- •4\. Are able and willing to complete the informed consent process
- •5\. Are aged over 60 years at the time of signing the Informed Consent Form
Exclusion Criteria
- •Patients who:
- •1\. Have (or have had) an oral tumour
- •2\. Require an obturator
- •3\. Have extreme xerostomia (e.g. Sjögren's syndrome)
- •4\. Have a denture stomatitis
- •5\. Have known hypersensitivity to dental materials used in the research
- •6\. Are incapable of providing written informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Ridge augmentation with autogenous bone versus the combination of xenogenic graft material and a grooth factor (BMP2)Difference of percepetion/acceptance in patients trated with autogonous bone blocks or xenogenic bone block loaded with BMP2 to create a sufficent bonesituation Difference in quantity and quality of the augmented boneMedDRA version: 14.1 Level: PT Classification code 10064143 Term: Dental implantation System Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Dentistry [E06]EUCTR2012-002002-46-ATniversitätsklinik für Zahn-, Mund- und Kieferheilkunde, Med Uni Graz, Department für zahnärztliche Chirurgie24
Recruiting
Phase 3
Role of Nelfinavir during chemoradiation for Cervical CancerHealth Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedCTRI/2017/08/009265Tata Memorial Centre and Varian International
Completed
Phase 3
Does the addition of tamoxifen to standard chemotherapy improve the time to progression of disease in women with advanced ovarian cancer?Advanced carcinoma of the ovaryCancer - Ovarian and primary peritonealACTRN12606000300572The Cancer Council Victoria230
Completed
Not Applicable
Phase III project, randomised controlled trial of brief intervention for illicit drugs linked to the World Health Organization (WHO) alcohol, smoking and substance involvement screening test (ASSIST): multicentre study conducted in Australia, Brazil, India, Spain, Thailand and USASubstance abuseMental and Behavioural DisordersISRCTN39055704World Health Organization (WHO)/The Department of Mental Health and Substance Abuse (MSD) (Switzerland)1,047
Completed
Not Applicable
Randomized controlled clinical study for 3-D volumetric evaluation of two techniques for periimplant guided bone regeneration proceduresK08.1Loss of teeth due to accident, extraction or local periodontal diseaseDRKS00005974niversität Zürich, Zentrum für Zahnmedizin, Klinik für Rekonstruktive Zahnmedizin27